Chirurgická léčba a management kožního spinocelulárního karcinomu u pacienta s dystrofickou bulózní epidermolýzou

Stáhnout PDF

Autoři: Rotschein P. ^1,2,4,5; Vokurková J. ^1,2,4,5; Bučková- H. ^{3 5}
Působiště autorů: Department of Pediatric Surgery, Orthopedics and Traumatology, University Hospital Brno, Czech Republic ¹; Department of Burns and Plastic surgery ²; Department of Pediatric Dermatology, University Hospital Brno, Czech Republic ³; Faculty of Medicine, Masaryk University, Brno, Czech Republic ⁴; EB center Czech Republic ⁵
Vyšlo v časopise: ACTA CHIRURGIAE PLASTICAE, 63, 4, 2021, pp. 196-200
doi: https://doi.org/10.48095/ccachp2021196

Zdroje

1. Has C., Bauer J., Bodemer C., et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Brit J Dermatol. 2020; 183(4): 614–627.

2. Mellerio J., Robertson S., Bernardis C., et al. Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines. Brit J Dermatol. 2015; 174(1): 56–67.

3. Dang N., Murrell D.. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa. Exp Dermatol. 2008; 17(7): 553–568.

4. Marks R. Squamous cell carcinoma. Lancet 1996; 347(9003): 735–738.

5. Fine J.D., Johnson L.B., Weiner M., et al. Epidermolysis bullosa and the risk of life-threatening cancers: the national EB registry experience, 1986–2006. J Am Acad Dermatol. 2009; 60:203–11.

6. Schmitz L., Kanitakis J. Histological classification of cutaneous squamous cell carcinomas with different severity. J Eur Acad Dermatol. 2019; 33(S8): 11–15.

7. Mallipeddi R. Epidermolysis bullosa and cancer. Clin Exp Dermatol. 2002; 27(8): 616–623.

8. Reed W.B., College J., Francis M.J., et al. Epidermolysis bullosa dystrophica with epidermal neoplasms. Arch Dermatol. 1974; 110: 894–902.

9. Mackie G.C., Avram A.M. FDG PET imaging features of epidermolysis bullosa complicated by squamous cell carcinoma. Clin Nucl Med. 2005; 30: 69–71.

10. Montaudié H., Chiaverini C., Sbidian E., et al. Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases. Orphanet J Rare Dis. 2016; 11: 117.

11. Meola S., Olivieri M., Mirabile C., et al. Anesthetic management for right upper extremity amputation due to recidivous cutaneous carcinoma and acute postoperative pain control in patients affected by epidermolysis bullosa. Minerva Anestesiol. 2010; 76: 144–147.

12. Rodriguez-Lojo R., Fernandez-Jorge B.,

De Andres A., et al. Wound closure by secondary intention is successful in the treatment of squamous cell carcinomas in recessive dystrophic epidermolysis bullosa. Eur J Dermatol. 2011; 21: 302–303.

13. Yamada M., Hatta N., Sogo K., et al. Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica. Dermatol Surg. 2004; 30(11): 1424–1429.

14. Hsieh C., Kuo Y., Huang P., et al. Free anterolateral thigh perforator flap for reconstruction of dystrophic epidermolysis bullosa-associated squamous cell carcinoma in the foot: case report. Ann of Plas Surg. 2003; 50(2): 201–203.

15. Migden M., Khushalani N., Chang A., et al. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial. Lancet Oncol. 2020; 21(2): 294–305.